| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |